Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel disease-modifying osteoarthritis drug candidate targeting Runx1.

A novel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis. 2013 May; 72(5):748-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.